依沃西披露OS获益,康方半年报释放了什么信号?

医药魔方
Aug 27, 2025

8月27日,康方生物股价高开4.7%后开始震荡下滑,这一市场反应,很大程度与其昨日晚间的半年报有关。财报显示,上半年康方生物实现营收14.11亿元,同比增长37.75%,对应亏损由上年同期的2.49亿元扩至今年上半年的5.88亿元。从收入构成来看,商业销售收入及商业授权收入是其两大支柱。其中,销售收入上半年同比增长49.20%至约14亿元,这一“爆发式增长”的背后,核心驱动力来自两款全球首创双抗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10